ATE363900T1 - Therapeutisches pflaster mit capsaicin-haltiger polysiloxan-matrix - Google Patents

Therapeutisches pflaster mit capsaicin-haltiger polysiloxan-matrix

Info

Publication number
ATE363900T1
ATE363900T1 AT03779987T AT03779987T ATE363900T1 AT E363900 T1 ATE363900 T1 AT E363900T1 AT 03779987 T AT03779987 T AT 03779987T AT 03779987 T AT03779987 T AT 03779987T AT E363900 T1 ATE363900 T1 AT E363900T1
Authority
AT
Austria
Prior art keywords
therapeutic compound
capsaicin
containing polysiloxane
polysiloxane matrix
therapeutic plaster
Prior art date
Application number
AT03779987T
Other languages
English (en)
Inventor
Walter Mueller
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Application granted granted Critical
Publication of ATE363900T1 publication Critical patent/ATE363900T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T156/00—Adhesive bonding and miscellaneous chemical manufacture
    • Y10T156/10—Methods of surface bonding and/or assembly therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT03779987T 2003-04-14 2003-11-19 Therapeutisches pflaster mit capsaicin-haltiger polysiloxan-matrix ATE363900T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46263003P 2003-04-14 2003-04-14

Publications (1)

Publication Number Publication Date
ATE363900T1 true ATE363900T1 (de) 2007-06-15

Family

ID=33159857

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03779987T ATE363900T1 (de) 2003-04-14 2003-11-19 Therapeutisches pflaster mit capsaicin-haltiger polysiloxan-matrix

Country Status (23)

Country Link
US (2) US8821920B2 (de)
EP (1) EP1613297B1 (de)
JP (1) JP4943657B2 (de)
KR (1) KR101050672B1 (de)
CN (2) CN100512806C (de)
AT (1) ATE363900T1 (de)
AU (1) AU2003289710B2 (de)
BR (1) BRPI0318250B8 (de)
CA (1) CA2517493C (de)
CY (1) CY1106744T1 (de)
DE (1) DE60314298T2 (de)
DK (1) DK1613297T3 (de)
ES (1) ES2288222T3 (de)
IL (1) IL171249A (de)
MX (1) MXPA05011012A (de)
NO (1) NO337896B1 (de)
NZ (1) NZ541956A (de)
PL (1) PL219512B1 (de)
PT (1) PT1613297E (de)
RU (1) RU2349315C9 (de)
UA (1) UA81665C2 (de)
WO (1) WO2004089361A1 (de)
ZA (1) ZA200506462B (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2535045T3 (es) * 2003-04-10 2015-05-04 Vanderbilt Royalty Sub L.P. Usos y composiciones para administración de capsaicina
DE102004044578A1 (de) * 2004-09-13 2006-03-30 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit einer Haftschicht, Verfahren zum Silikonisieren einer Rückschicht des Systems und Verwendung der Rückschicht
JP2006206471A (ja) * 2005-01-26 2006-08-10 Nitto Denko Corp テープ製剤
EP1858495A2 (de) * 2005-02-14 2007-11-28 Neurogesx, Inc. Vorrichtung zur abgabe von trpv1-agonisten
US20060222690A1 (en) * 2005-03-30 2006-10-05 Bley Keith R Low-concentration capsaicin patch and methods for treating neuropathic pain
JP4505645B2 (ja) * 2006-02-17 2010-07-21 フジコピアン株式会社 固定シートの貼付方法
JP4505644B2 (ja) * 2006-02-17 2010-07-21 フジコピアン株式会社 固定シート
JP4505646B2 (ja) * 2006-02-20 2010-07-21 フジコピアン株式会社 固定シート
JP4505649B2 (ja) * 2006-03-23 2010-07-21 フジコピアン株式会社 固定シート
JP2007284370A (ja) * 2006-04-14 2007-11-01 Alcare Co Ltd 体表面用貼付材
US7943666B2 (en) * 2006-07-24 2011-05-17 Trinity Laboratories, Inc. Esters of capsaicin for treating pain
EP2155175B1 (de) * 2007-06-08 2014-03-12 Samyang Biopharmaceuticals Corporation Matrixartiges transdermales wirkstofffreisetzungssystem und herstellungsverfahren dafür
WO2011155542A1 (ja) * 2010-06-09 2011-12-15 花王株式会社 水蒸気発生温熱具
TW201431570A (zh) 2012-11-22 2014-08-16 Ucb Pharma Gmbh 用於經皮投服羅替戈汀（Ｒｏｔｉｇｏｔｉｎｅ）之多天式貼片
KR20150129733A (ko) * 2013-03-14 2015-11-20 알러간, 인코포레이티드 비마토프로스트를 포함하는 국소 조성물 및 이를 사용하여 모발 성장을 자극하는 방법
AP2015008920A0 (en) * 2013-06-04 2015-12-31 Lohmann Therapie Syst Lts Transdermal delivery system
JP6726096B2 (ja) 2013-07-03 2020-07-22 エルテーエス ローマン テラピー−システメ アーゲー 電子部品を有する経皮治療システム
CN104586818A (zh) * 2013-11-01 2015-05-06 北京中卫神农慢性病医学研究院有限公司 辣椒碱微孔久释器材
KR101574760B1 (ko) * 2013-11-13 2015-12-04 주식회사 엘지생활건강 흡수속도를 개선한 마이크로니들 시스템
CA2948219C (en) 2014-05-20 2023-04-04 Lts Lohmann Therapie-Systeme Ag Method for adjusting the release of active agent in a transdermal delivery system
CN106456566B (zh) 2014-05-20 2020-06-16 Lts勒曼治疗系统股份公司 含罗替戈汀的经皮递送系统
US11752110B2 (en) 2014-05-20 2023-09-12 Lts Lohmann Therapie-Systeme Ag Transdermal delivery system including an interface mediator
MA40998A (fr) 2014-11-21 2017-09-26 Ophirex Inc Thérapies contre une envenimation, ainsi que compositions, systèmes et kits pharmaceutiques associés
CN104546805A (zh) * 2014-12-15 2015-04-29 刘闯 一种治疗皮肤色斑的药膏贴
EP3266472A1 (de) * 2016-07-08 2018-01-10 Mölnlycke Health Care AB Medizinischer verband mit einem träger und einem verbundstoffmaterial
KR101880442B1 (ko) * 2017-02-02 2018-07-23 대구한의대학교산학협력단 혈압 강하용 패치 조성물
US12383509B2 (en) * 2017-09-04 2025-08-12 Lts Lohmann Therapie-Systeme Ag Transdermal delivery system including an emulsifier
KR20220154160A (ko) 2020-03-17 2022-11-21 그뤼넨탈 게엠베하 초기 무반응자를 치료하기 위한 캡사이신 패치의 반복된 국소 적용
WO2021198524A1 (en) 2020-04-03 2021-10-07 Grünenthal GmbH Regimen for repeated topical application of capsaicin patch
TWI807338B (zh) * 2020-06-26 2023-07-01 美商美國禮來大藥廠 結合ＴＧＦ-α及表皮調節素（ＥＰＩＲＥＧＵＬＩＮ）之抗體於治療疼痛之用途
US11234947B2 (en) * 2020-06-30 2022-02-01 Imperial College Innovations Limited Treatment of peripheral neuropathy induced by cancer chemotherapy
JP7683009B2 (ja) * 2020-12-30 2025-05-26 エルケム・シリコーンズ・シャンハイ・カンパニー・リミテッド カプサイシン含有シリコーンゲルでコーティングされたパッチ
EP4046630A1 (de) * 2021-02-18 2022-08-24 LTS Lohmann Therapie-Systeme AG Tts-formulierung mit thc
AR125902A1 (es) 2021-05-21 2023-08-23 Lilly Co Eli Compuestos y métodos dirigidos a epirregulina
EP4680210A1 (de) * 2023-03-15 2026-01-21 LTS Lohmann Therapie-Systeme AG Medizinisches pflaster mit hautreizendem wirkstoff
CN120752028A (zh) * 2023-03-15 2025-10-03 Lts罗曼治疗系统股份公司 包含辣椒素的医用贴剂
CN121816174A (zh) * 2023-10-23 2026-04-07 Lts罗曼治疗系统股份公司 包含辣椒素或辣椒素类似物的医用贴剂

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3946106A (en) 1974-10-24 1976-03-23 G. D. Searle & Co. Microsealed pharmaceutical delivery device
US4053580A (en) 1975-01-01 1977-10-11 G. D. Searle & Co. Microsealed pharmaceutical delivery device
DE3333240A1 (de) * 1983-09-12 1985-03-28 Schering AG, 1000 Berlin und 4709 Bergkamen Mittel zur transdermalen applikation von arzneimittelwirkstoffen
US5145682A (en) 1986-05-30 1992-09-08 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration
GB8704755D0 (en) 1987-02-28 1987-04-01 Dow Corning Ltd Pharmaceutical delivery device
US5788983A (en) * 1989-04-03 1998-08-04 Rutgers, The State University Of New Jersey Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes
US5494680A (en) * 1993-12-08 1996-02-27 Minnesota Mining And Manufacturing Company Transdermal delivery device
CN1037242C (zh) * 1994-04-22 1998-02-04 天津轻工业学院 以干红辣椒为原料制备辣椒碱的方法
US5714162A (en) * 1994-09-16 1998-02-03 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Scopolamine patch
US5762963A (en) 1995-06-07 1998-06-09 Emory University Method and compositions for controlling oral and pharyngeal pain using capsaicinoids
US6248788B1 (en) 1996-11-06 2001-06-19 The Regents Of The University Of California Therapeutic method with capsaicin and capasicin analogs
US6239180B1 (en) * 1995-11-08 2001-05-29 The Regents Of The University Of California Transdermal therapeutic device and method with capsaicin and capsaicin analogs
RU2097057C1 (ru) * 1995-11-15 1997-11-27 Акционерное общество открытого типа "Нижегородский химико-фармацевтический завод" Состав мази болеутоляющего и местнораздражающего действия с тепловым эффектом
GB2340751B (en) * 1998-08-12 2003-11-05 Edko Trading Representation Pharmaceutical compositions
CA2267049A1 (en) * 1999-02-05 2000-08-05 Bioglan Laboratories Ltd. Pharmaceutical compositions
DE19923427A1 (de) * 1999-05-21 2000-11-23 Lohmann Therapie Syst Lts Vorrichtung und Verfahren zur Steigerung der transdermalen Permeation von Arzneistoffen
CN1195505C (zh) * 1999-07-02 2005-04-06 Lts勒曼治疗系统股份公司 以聚硅氧烷及亲两性溶剂为基础的微贮存系统
DE19958554C2 (de) * 1999-07-02 2002-06-13 Lohmann Therapie Syst Lts Mikroreservoirsystem auf Basis von Polysiloxanen und ambiphilen Lösemitteln und ihre Herstellung
US6348501B1 (en) * 1999-09-29 2002-02-19 Medical Merchandising, Inc. Lotion compositions utilizing capsaicin
DE10025971B4 (de) * 2000-05-25 2004-09-02 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System in Plasterform mit verminderter Tendenz zur Wirkstoffkristallisation und seine Verwendung
DE10114382A1 (de) * 2001-03-23 2002-09-26 Beiersdorf Ag Feuchtigkeitsaufnehmende Matrix auf Silikonbasis insbesondere zur Wundversorgung und/oder pharmazeutisch/kosmetischen Hautbehandlung
JP3989188B2 (ja) * 2001-04-27 2007-10-10 クリストファー・エム・キム 蜂針を用いない蜂毒療法
EP1390084B1 (de) * 2001-05-01 2011-03-23 A.V. Topchiev Institute of Petrochemical Synthesis Zweiphasige, wasserabsorbierende bioadhäsive zusammenstezung
DE10141651B4 (de) * 2001-08-24 2007-02-15 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung
AU2002323151A1 (en) * 2001-08-13 2003-03-03 University Of Pittsburgh Application of lipid vehicles and use for drug delivery
CA2460352C (en) * 2001-08-17 2013-05-14 Lavipharm Laboratories Inc. Composition and transdermal drug delivery device
US8246979B2 (en) * 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system for the administration of rotigotine

Also Published As

Publication number Publication date
EP1613297B1 (de) 2007-06-06
ES2288222T3 (es) 2008-01-01
CN101601664A (zh) 2009-12-16
MXPA05011012A (es) 2005-12-12
US20140335150A1 (en) 2014-11-13
CA2517493A1 (en) 2004-10-21
DE60314298D1 (de) 2007-07-19
RU2349315C2 (ru) 2009-03-20
PT1613297E (pt) 2007-08-23
JP2006514977A (ja) 2006-05-18
RU2005134984A (ru) 2007-05-27
CN100512806C (zh) 2009-07-15
BR0318250A (pt) 2006-05-23
US8821920B2 (en) 2014-09-02
NO337896B1 (no) 2016-07-04
JP4943657B2 (ja) 2012-05-30
ZA200506462B (en) 2006-05-31
WO2004089361A1 (en) 2004-10-21
UA81665C2 (ru) 2008-01-25
EP1613297A1 (de) 2006-01-11
CN1784222A (zh) 2006-06-07
KR20060002997A (ko) 2006-01-09
RU2349315C9 (ru) 2010-02-27
CA2517493C (en) 2011-05-31
DK1613297T3 (da) 2007-09-24
HK1090844A1 (zh) 2007-01-05
NZ541956A (en) 2008-09-26
BRPI0318250B8 (pt) 2021-05-25
PL219512B1 (pl) 2015-05-29
US20040202707A1 (en) 2004-10-14
DE60314298T2 (de) 2008-01-31
BRPI0318250B1 (pt) 2015-08-11
PL378806A1 (pl) 2006-05-15
CY1106744T1 (el) 2012-05-23
AU2003289710B2 (en) 2009-07-30
NO20055310L (no) 2005-11-10
HK1136957A1 (en) 2010-07-16
CN101601664B (zh) 2012-05-23
IL171249A (en) 2010-06-16
AU2003289710A1 (en) 2004-11-01
KR101050672B1 (ko) 2011-07-19

Similar Documents

Publication Publication Date Title
ATE363900T1 (de) Therapeutisches pflaster mit capsaicin-haltiger polysiloxan-matrix
PT1524975E (pt) Sistema aperfeicoado de administracao transdermica para a administracao de rotigotina
ATE352293T1 (de) Transdermales therapeutisches system mit fentanyl
RU2009123368A (ru) Трансдермальная терапевтическая система для введения активного вещества бупренорфина
JP2007538008A5 (de)
TW200637529A (en) Topical patch cooling preparation and methods for using the same
BR112015013660A2 (pt) sistema de entrega transdérmica
BR0215404A (pt) processo e dispositivo para reduzir dosagem terapêutica
WO2007095615A3 (en) Use of benzo-heteroaryl sulfamide derivatives for the treatmentof pain
ATE422877T1 (de) Zusammensetzungen zur haarbehandlung
ATE438623T1 (de) Aroyl-o-piperidinderivate zur behandlung von problemen im zusammenhang mit diabetes
DE502005008058D1 (de) Gesättigte und ungesättigte 3-pyridyl-benzocycloalkylmethyl-amine zur behandlung von schmerzen, depressionen und angstzuständen
ATE447948T1 (de) Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur behandlung von schmerzen
EA201300648A1 (ru) Трансдермальная терапевтическая система (tts), содержащая ротиготин
DK1524971T3 (da) Forbedret transdermalt leveringssystem
HK1220125A1 (zh) 拉喹莫德的透皮配方
ATE468849T1 (de) Idebenon zur behandlung von muskeldystrophien
JP2003212765A (ja) 水虫の活動を停止させる溶液
DE20221247U1 (de) Transdermal-Pflaster zum Verabreichen von Fentanyl
IL182297A (en) Use of winter savory (satureja montana) or the extracts thereof for the preparation of medicaments for the treatment of the premature ejaculation
CN201171749Y (zh) 一种治疗脚气用的创可贴
JP2009221445A (ja) カツラ用ゴム系接着剤
CO6450633A2 (es) Parche terapeutico para puntos de trigger y acupuntura para la terapia meridiana
JP2009106715A (ja) 磁石又はゲルマニウム入りシップ剤
ATE425765T1 (de) Verwendung von kollagen in kombination mit sauerstoff- und ozon-freisetzenden perfluorkohlenwasserstoffen zur herstellung eines medikaments zur behandlung von hautverletzungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1613297

Country of ref document: EP